Acute Renal Failure Trial Network (ATN) Study

PHASE3CompletedINTERVENTIONAL
Enrollment

1,124

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

September 30, 2007

Study Completion Date

July 31, 2008

Conditions
Acute Renal Failure
Interventions
PROCEDURE

renal replacement therapy

renal replacement therapy

Trial Locations (22)

14215

VA Western New York Healthcare System at Buffalo, Buffalo

15240

VA Pittsburgh Health Care System, Pittsburgh

21201

VA Maryland Health Care System, Baltimore, Baltimore

23249

Hunter Holmes McGuire VA Medical Center, Richmond

30904

VA Medical Center, Augusta, Augusta

33125

VA Medical Center, Miami, Miami

44106

VA Medical Center, Cleveland, Cleveland

48113

VA Ann Arbor Healthcare System, Ann Arbor

63106

VA Medical Center, St Louis, St Louis

75216

VA North Texas Health Care System, Dallas, Dallas

77030

Michael E. DeBakey VA Medical Center (152), Houston

80220

VA Eastern Colorado Health Care System, Denver, Denver

90073

VA Greater Los Angeles Healthcare System, West LA, West Los Angeles

94121

VA Medical Center, San Francisco, San Francisco

97201

VA Medical Center, Portland, Portland

98108

VA Puget Sound Health Care System, Seattle, Seattle

72114-1706

Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock, No. Little Rock

06516

VA Connecticut Health Care System (West Haven), West Haven

46202-2884

Richard Roudebush VA Medical Center, Indianapolis, Indianapolis

02130

VA Medical Center, Jamaica Plain Campus, Boston

27157-1053

Wake Forest University School of Medicine, Winston-Salem

37212-2637

VA Medical Center, Nashville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

US Department of Veterans Affairs

FED

NCT00076219 - Acute Renal Failure Trial Network (ATN) Study | Biotech Hunter | Biotech Hunter